Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.02 B DKK
17.90 B DKK
342.12 M
About NOVONESIS (NOVOZYMES A/S) B
Sector
CEO
Ester Baiget
Headquarters
Lyngby
Website
ISIN
DK0060336014
FIGI
BBG000BLL8K7
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NSIS_B is 408.9 DKK — it has increased by 1.68% in the past 24 hours. Watch NOVONESIS (NOVOZYMES A/S) B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange NOVONESIS (NOVOZYMES A/S) B stocks are traded under the ticker NSIS_B.
NSIS_B stock has fallen by −1.48% compared to the previous week, the month change is a −10.27% fall, over the last year NOVONESIS (NOVOZYMES A/S) B has showed a 13.33% increase.
We've gathered analysts' opinions on NOVONESIS (NOVOZYMES A/S) B future price: according to them, NSIS_B price has a max estimate of 586.04 DKK and a min estimate of 364.03 DKK. Watch NSIS_B chart and read a more detailed NOVONESIS (NOVOZYMES A/S) B stock forecast: see what analysts think of NOVONESIS (NOVOZYMES A/S) B and suggest that you do with its stocks.
NSIS_B reached its all-time high on Jan 4, 2022 with the price of 545.8 DKK, and its all-time low was 25.0 DKK and was reached on Jan 29, 2003. View more price dynamics on NSIS_B chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NSIS_B stock is 1.82% volatile and has beta coefficient of 0.36. Track NOVONESIS (NOVOZYMES A/S) B stock price on the chart and check out the list of the most volatile stocks — is NOVONESIS (NOVOZYMES A/S) B there?
Today NOVONESIS (NOVOZYMES A/S) B has the market capitalization of 188.31 B, it has decreased by −0.44% over the last week.
Yes, you can track NOVONESIS (NOVOZYMES A/S) B financials in yearly and quarterly reports right on TradingView.
NOVONESIS (NOVOZYMES A/S) B is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
NSIS_B earnings for the last quarter are 2.67 DKK per share, whereas the estimation was 3.83 DKK resulting in a −30.34% surprise. The estimated earnings for the next quarter are 4.89 DKK per share. See more details about NOVONESIS (NOVOZYMES A/S) B earnings.
NOVONESIS (NOVOZYMES A/S) B revenue for the last quarter amounts to 7.61 B DKK, despite the estimated figure of 7.51 B DKK. In the next quarter, revenue is expected to reach 7.41 B DKK.
NOVONESIS (NOVOZYMES A/S) B dividend yield was 1.67% in 2023, and payout ratio reached 56.80%. The year before the numbers were 1.71% and 45.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 6.76 K employees. See our rating of the largest employees — is NOVONESIS (NOVOZYMES A/S) B on this list?
Like other stocks, NSIS_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVONESIS (NOVOZYMES A/S) B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVONESIS (NOVOZYMES A/S) B technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVONESIS (NOVOZYMES A/S) B stock shows the buy signal. See more of NOVONESIS (NOVOZYMES A/S) B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.